Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
McKinsey
AstraZeneca
Cipla
Accenture
US Army
Harvard Business School
Novartis
Covington
Chubb

Generated: August 19, 2017

DrugPatentWatch Database Preview

Pohl Boskamp Company Profile

« Back to Dashboard

What is the competitive landscape for POHL BOSKAMP, and what generic alternatives to POHL BOSKAMP drugs are available?

POHL BOSKAMP has three approved drugs.

There are two US patents protecting POHL BOSKAMP drugs.

There are sixteen patent family members on POHL BOSKAMP drugs in eight countries.

Summary for Applicant: Pohl Boskamp

Patents:2
Tradenames:5
Ingredients:1
NDAs:3
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pohl Boskamp
NITROLINGUAL PUMPSPRAY
nitroglycerin
SPRAY, METERED;SUBLINGUAL018705-002Jan 10, 1997ABRXYesYes► Subscribe► SubscribeY ► Subscribe
Pohl Boskamp
GONITRO
nitroglycerin
POWDER;SUBLINGUAL208424-001Jun 8, 2016RXYesYes► Subscribe► SubscribeY ► Subscribe
Pohl Boskamp
NITRONAL
nitroglycerin
INJECTABLE;INJECTION018672-001Aug 30, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Pohl Boskamp
NITROLINGUAL
nitroglycerin
AEROSOL;SUBLINGUAL018705-001Oct 31, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Pohl Boskamp
NITRO IV
nitroglycerin
INJECTABLE;INJECTION018672-002Aug 30, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Pohl Boskamp

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pohl Boskamp
NITROLINGUAL PUMPSPRAY
nitroglycerin
SPRAY, METERED;SUBLINGUAL018705-002Jan 10, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for POHL BOSKAMP drugs

Drugname Dosage Strength Tradename Submissiondate
nitroglycerin
Sublingual Spray400 mcg/spray, 4.9 g and 12 g bottles
NITROLINGUAL PUMPSPRAY
8/23/2012
nitroglycerin
Sublingual Spray400 mcg/spray, 4.9 g and 12 g bottles
NITROLINGUAL PUMPSPRAY
4/17/2012

Non-Orange Book Patents for Pohl Boskamp

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,616,023Stabilized granules containing glyceryl trinitrate► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Pohl Boskamp Drugs

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)2012113564► Subscribe
Australia2012219925► Subscribe
Australia2012219926► Subscribe
World Intellectual Property Organization (WIPO)2012113563► Subscribe
Israel208151► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Citi
McKinsey
Federal Trade Commission
Accenture
US Army
Fish and Richardson
Harvard Business School
Chinese Patent Office
Daiichi Sankyo
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot